The day he puts a decent amount of money into it is the day I take his appointment seriously. Not options issued to him as a payment for services as a director.
These directors have excellent credentials, with degrees out the wazoo, but I will take results over a degree any day. A director with regulatory experience would be very useful.
The CR is next and I don't know how u issue shares at a higher price without some really good news, so I presume some good news is next, then a CR then the plan to execute clinical trial and finally those last fiddly little bits to get approval.
I will watch patiently until that approval is looking likely, again, because that has been this company's greatest weakness.
Btw, if an expert like CB says vitro-gro wont be super competitive in the US market, the intelligent thing is not to say he lacks loyalty, but to find out why he thinks that !
TIS Price at posting:
6.0¢ Sentiment: Hold Disclosure: Held
